A detailed history of Israel Englander (Millennium Management LLC) transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,398,876 shares of LXRX stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,398,876
Previous 597,321 134.19%
Holding current value
$1.16 Million
Previous $1 Million 118.94%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.51 - $2.39 $1.21 Million - $1.92 Million
801,555 Added 134.19%
1,398,876 $2.2 Million
Q2 2024

Aug 14, 2024

BUY
$1.54 - $2.28 $97,230 - $143,952
63,137 Added 11.82%
597,321 $1 Million
Q1 2024

May 15, 2024

SELL
$1.3 - $3.58 $1.43 Million - $3.93 Million
-1,098,992 Reduced 67.29%
534,184 $1.28 Million
Q4 2023

Feb 14, 2024

SELL
$1.0 - $1.53 $1 Million - $1.53 Million
-1,000,997 Reduced 38.0%
1,633,176 $2.5 Million
Q2 2023

Aug 14, 2023

BUY
$2.15 - $3.49 $5.61 Million - $9.11 Million
2,610,329 Added 10947.53%
2,634,173 $6.03 Million
Q1 2023

May 15, 2023

SELL
$1.99 - $2.68 $2.29 Million - $3.09 Million
-1,152,723 Reduced 97.97%
23,844 $58,000
Q4 2022

Feb 14, 2023

BUY
$1.8 - $2.56 $487,180 - $692,879
270,656 Added 29.88%
1,176,567 $2.25 Million
Q3 2022

Nov 14, 2022

BUY
$1.94 - $3.43 $1.33 Million - $2.36 Million
687,963 Added 315.65%
905,911 $2.17 Million
Q2 2022

Aug 15, 2022

SELL
$1.31 - $2.69 $197,424 - $405,399
-150,706 Reduced 40.88%
217,948 $405,000
Q1 2022

May 16, 2022

BUY
$1.95 - $3.89 $221,356 - $441,577
113,516 Added 44.49%
368,654 $770,000
Q4 2021

Feb 14, 2022

BUY
$3.81 - $6.16 $674,754 - $1.09 Million
177,101 Added 226.94%
255,138 $1.01 Million
Q3 2021

Nov 15, 2021

SELL
$3.38 - $5.35 $344,144 - $544,726
-101,818 Reduced 56.61%
78,037 $375,000
Q2 2021

Aug 16, 2021

SELL
$4.12 - $5.87 $15,787 - $22,493
-3,832 Reduced 2.09%
179,855 $826,000
Q1 2021

May 17, 2021

SELL
$3.45 - $9.09 $2.57 Million - $6.77 Million
-744,486 Reduced 80.21%
183,687 $1.08 Million
Q4 2020

Feb 16, 2021

BUY
$1.05 - $3.67 $839,217 - $2.93 Million
799,255 Added 619.97%
928,173 $3.17 Million
Q3 2020

Nov 16, 2020

BUY
$1.44 - $2.1 $185,641 - $270,727
128,918 New
128,918 $186,000
Q1 2020

May 14, 2020

SELL
$1.8 - $4.28 $2.36 Million - $5.61 Million
-1,309,722 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$3.16 - $5.15 $281,533 - $458,828
89,093 Added 7.3%
1,309,722 $5.44 Million
Q3 2019

Nov 14, 2019

BUY
$1.2 - $6.66 $1.42 Million - $7.89 Million
1,184,819 Added 3308.63%
1,220,629 $3.67 Million
Q2 2019

Aug 15, 2019

SELL
$5.35 - $7.11 $6.05 Million - $8.05 Million
-1,131,727 Reduced 96.93%
35,810 $225,000
Q2 2019

Aug 14, 2019

BUY
$5.35 - $7.11 $6.01 Million - $7.99 Million
1,123,929 Added 2577.35%
1,167,537 $36.9 Million
Q1 2019

May 14, 2019

SELL
$4.36 - $7.94 $224,805 - $409,394
-51,561 Reduced 54.18%
43,608 $242,000
Q4 2018

Feb 14, 2019

BUY
$6.15 - $10.51 $72,951 - $124,669
11,862 Added 14.24%
95,169 $632,000
Q3 2018

Nov 14, 2018

SELL
$10.32 - $13.06 $3.57 Million - $4.52 Million
-346,046 Reduced 80.6%
83,307 $889,000
Q2 2018

Aug 14, 2018

BUY
$7.8 - $13.69 $3.35 Million - $5.88 Million
429,353 New
429,353 $5.15 Million
Q1 2018

May 15, 2018

SELL
$7.86 - $11.39 $3 Million - $4.34 Million
-381,266 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$8.77 - $12.28 $22,845 - $31,989
-2,605 Reduced 0.68%
381,266 $3.77 Million
Q3 2017

Nov 14, 2017

BUY
$12.17 - $16.3 $4.67 Million - $6.26 Million
383,871
383,871 $4.72 Million

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.